Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Dopamine Receptor D1 ELISA Kit (AC2906)
Cat.#: ASET-1495
Specifications
Description Mouse Dopamine Receptor D1 ELISA Kit allows for the in vitro quantitative determination of mouse Dopamine Receptor D1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2293 Mouse Wnt5a ELISA Kit (AC3704) Quantitative inquiry ASET-2085 Mouse S1PR2 ELISA Kit (AC3496) Quantitative inquiry ASET-1589 Mouse Ki67 ELISA Kit (AC3000) Quantitative inquiry ASET-2197 Human HSD17B1 ELISA Kit (AC3608) Quantitative inquiry ASET-1364 Rat Dio3 ELISA Kit (AC2775) Quantitative inquiry ASET-1512 Human P2Y1 ELISA Kit (AC2923) Quantitative inquiry ASET-1889 Human Toca-1 ELISA Kit (AC3300) Quantitative inquiry ASET-2049 Human Neuromedin B ELISA Kit (AC3460) Quantitative inquiry ASET-1604 Rabbit IL-6 ELISA Kit (AC3015) Quantitative inquiry ASET-1059 Human HMT ELISA Kit (AC2470) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket